| 3.28 Data as of May 20 |  0.00 / 0.00%Today’s Change | 2.13 Today|||52-Week Range 3.82 | +39.57% Year-to-Date |
| Previous close | 3.28 |
| Today’s open | 3.33 |
| Day’s range | -- - -- |
| Volume | 54,433 |
| Average volume (3 months) | 56,737 |
| Market cap | $46.7M |
| Dividend yield | -- |
| Earnings growth (last year) | -40.44% |
| Earnings growth (this year) | +28.66% |
| Earnings growth (next 5 years) | +23.70% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 1.50 |
| Today’s change | Today’s % change | |
|---|---|---|
| HSKAHeska Corp | -0.08 | -0.99% |
| BGMDBG Medicine Inc | -0.01 | -0.59% |
| DMPIDelMar Pharmaceutica... | -0.35 | -14.29% |
| CMXICytomedix Inc | -0.04 | -8.00% |
| Next reporting date | August 7, 2013 |
| EPS forecast (this quarter) | -$0.37 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$20.7M |
| Net profit margin | -- |
Sector Health Technology |
Industry Pharmaceuticals: Other |
President, Chief Executive Officer & Director Errol B. De Souza, PhD |
Vice President- Operations Eric I. Steiner, MD, MBA |
Corporate headquarters Danbury, Connecticut |
.
